Extension Study of PF‐05280586, a Potential Rituximab Biosimilar, Versus Rituximab in Subjects With Active Rheumatoid Arthritis - Cohen, Stanley B.; Burgos‐Vargas, Rubén; Emery, Paul; Jin, Bo; Cronenberger, Carol; Vázquez‐Abad, María‐Dolores (Arthritis care & research (2010), 2018)
Keywords: CD19 antigen; Immunogenicity; Immunotherapy; Intravenous administration; Lymphocytes B; Monoclonal antibodies; Original; Pharmacodynamics; Pharmacokinetics; Remission; Rheumatoid Arthritis; Rituximab; Safety; United States--US